Form 4: Elanco Animal Health Director Receives Stock Award

Stacey Ma, a director at Elanco Animal Health, received 2,539 shares of common stock as part of an annual equity award.

Summary

• Stacey Ma, a director of Elanco Animal Health, received 2,539 shares of common stock on November 29, 2024.
• The shares were granted as part of an annual equity award for non-employee members of the Board of Directors.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock awards to a director, which is a normal part of corporate governance. It is neither particularly positive nor negative.

Positives

• The grant of stock to a director aligns their interests with those of shareholders.
• Equity awards are a common practice for compensating board members.

Industry Context

The granting of stock awards to board members is a standard practice in publicly traded companies to align their interests with shareholders and incentivize their service.

Comparison to Industry Standards

• Stock awards to non-employee directors are a common practice across various industries, including the pharmaceutical and animal health sectors.
• Companies like Zoetis and IDEXX Laboratories also use equity compensation as part of their director compensation packages.
• The size of the award is likely determined by the company's compensation policy and the director's role.

Stakeholder Impact

• The stock award aligns the director's interests with those of shareholders.
• The award does not have a direct impact on employees, customers, or suppliers.

Key Dates

Keywords

Elanco Animal Health, stock award, equity compensation, director, Form 4, SEC filing, corporate governance